ICICI Securities analyst Abdulkader Puranwala downgraded Zydus Lifesciences (ZYDUSLIF:IN) from Hold (3) to Reduce (4) with a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE